While targeted treatments emerge continuously, the insurance benefit causes difficulties in the market

While many pharmaceutical companies had focused on the development of chronic disease treatments, such as hypertension and diabetes, in early-2000s, the latest new drug trend is the R&D of targeted agents and rare disease treatments.

The reason why pharmaceutical companies have worked so hard on the development of targeted agents is because the range of the development is broad and constant sa...